MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells

Author： Buisson S.   Triebel F.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.9, 2003-02, pp. : 862-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression

By Gagliardi M.C.   De Magistris M.T.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 856-861

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

CD19 regulates B cell antigen receptor-mediated MHC class II antigen processing

By Wagle N.M.   Kim J.H.   Pierce S.K.  

Vaccine, Vol. 18, Iss. 3, 1999-09 ,pp. : 376-386

Elsevier

Access to resources Recommend Favorite

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

By Audran R.   Peter K.   Dannull J.   Men Y.   Scandella E.   Groettrup M.   Gander B.   Corradin G.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1250-1255

Elsevier

Access to resources Recommend Favorite

Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1

By Rubinchik E.   Chow A.W.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2312-2320

Elsevier

Access to resources Recommend Favorite